Table of Contents
What changed
Gross rental revenue fell 16.4% to NZ$5.3m as portfolio divestments removed income. The pre-tax loss narrowed to NZ$5.3m from NZ$13.5m (PBT improved 60.8%), with NPAT moving in line at NZ$5.3m versus NZ$13.0m prior. Operating cash flow collapsed 84.2% to just NZ$0.4m (from NZ$2.7m). Capex on investment properties stepped down sharply to NZ$6.5m from NZ$58.2m as the build programme moderated. Gross borrowings were cut 53.8% to NZ$33.0m from NZ$71.4m, funded by the Stoddard Road sale (NZ$36.75m) plus a further NZ$7.1m applied to debt. Cash fell to NZ$3.7m from NZ$4.9m, leaving net debt at NZ$29.2m (vs NZ$66.5m). No dividend was declared; the prior-year comparable of NZ$0.404 per share reflects a payment suspended in March 2022 and was not a FY23 distribution in any operating sense.
What matters
- Debt reduction is the headline achievement. Gross borrowings down NZ$38.4m and net debt down NZ$37.3m materially de-risks the balance sheet against the high-rates backdrop management cited. Total liabilities fell 40.8%.
- Revenue base is shrinking alongside the portfolio. The 16.4% rental decline is the direct cost of the deleveraging strategy, and management flagged a potential Munroe Lane divestment — meaning the income base may contract further before it stabilises.
- Cash generation has effectively stalled. OCF of NZ$0.4m against NZ$6.5m of property capex produced pre-lease free cash flow of negative NZ$6.1m. Asset sale proceeds, not operations, are funding the company.
Expectations
No quantified forward work, earnings guidance or stated target was disclosed. Against the half-year shape, HY24 delivered 48.9% of full-year revenue but 89.1% of the full-year loss — the implied second half is a much smaller NZ$0.6m loss on NZ$2.7m of revenue, suggesting the cost base has begun to catch up with the smaller portfolio. That is directional support only; it does not establish a run-rate the release explicitly endorses.
Quality of result
The PBT improvement is real but low quality as an operating read. The prior-year comparable was heavily weighed down by revaluation and cycle effects not repeated at the same magnitude, and the current result still sits at a loss. Tax is not distorting (effective rates of 0% current and 3.4% prior), so PBT and NPAT move together. The more telling quality signal is cash: OCF of NZ$0.4m cannot fund NZ$6.5m of capex, and cash conversion deteriorated materially versus FY23. ROE improved to -3.8% from -8.9% but remains negative. The deleveraging benefit is durable; the P&L improvement is partly a base effect.
Unresolved
- Is the revenue base now stable, or does a Munroe Lane sale take it lower again?
- What is the post-deleveraging recurring-earnings capacity of the remaining portfolio, and when (if ever) does a dividend resume?
- What is current NTA per share, and how does it compare with the carrying value of assets being marketed for sale?
- What are interest cover and covenant headroom on the residual NZ$33.0m of borrowings?
This briefing cannot assess property-level valuations, tenant quality or lease expiry profile, nor the likelihood or pricing of a Munroe Lane transaction, because none of that detail was in the extracted materials.
Key metrics
| Metric | FY24 | FY23 | Change |
|---|---|---|---|
| Revenue | $5.3m | $6.4m | -16.4% ↓ |
| Net profit after tax | −$5.3m | −$13.0m | +59.4% ↑ |
| Net cash inflow from operating activities | $0.4m | $2.7m | -84.2% ↓ |
| Declared dividend per share | — | 40.4c | — |
| Profit before tax | −$5.3m | −$13.5m | +60.8% ↑ |
| Cash and cash equivalents | $3.7m | $4.9m | -23.2% ↓ |
| Total assets | $190.3m | $229.5m | -17.1% ↓ |
Reference: annolyse.ai/briefings/apl-fy24
Analytical metrics
| Metric | FY24 | FY23 | Context |
|---|---|---|---|
| FCF pre-lease | −$6.1m | −$55.5m | +$49.4m |
| FCF / NPAT | 115.1% | 425.2% | complementary conversion metric |
| Capex % revenue | 122.5% | 912.9% | — |
| Capex | −$6.5m | −$58.2m | +$51.7m |
| Debtor days | 0.0 | 1.5 | -1.5 days |
| Trade debtors | $0.0m | $0.0m | −$0.0m |
| Net debt | $29.2m | $66.5m | −$37.3m |
| Gross borrowings | $33.0m | $71.4m | −$38.4m |
| ROE (annualised) | -3.8% | -8.9% | Strengthening |
| HY24 share of FY24 revenue | 48.9% | — | Other half was 51.1% |
| HY24 share of FY24 NPAT | 89.1% | — | Other half was 10.9% |
| Profit from continuing operations | −$5.3m | −$13.0m | +$7.8m |
Reference: annolyse.ai/briefings/apl-fy24
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.